Inventor · disambiguated record
Stefan Ewert
Also filed as: EWERT STEFAN
16 granted patents·10 pending applications·53 citations·filing 2002–2024
91Inventor score
Files withNOVARTIS AG11ESBATECH ALCON BIOMED RES UNIT6EWERT STEFAN6CHENNAMSETTY NARESH1KOLBINGER FRANK1
Top patents by PatentIndex Score
26 records- 0192US8067547B2Stable and soluble antibodies inhibiting TNFαEWERT STEFAN·Filed 2006·Granted Nov 29, 2011·21 cites·41 claims
- 0286US10465011B2Factor XI antibodies and methods of useNOVARTIS AG·Filed 2016·Granted Nov 5, 2019·5 cites·16 claims
- 0385US10647780B2Reversal binding agents for anti-factor XI/XIa antibodies and uses thereofNOVARTIS AG·Filed 2017·Granted May 12, 2020·4 cites·17 claims
- 0484US11932681B2Hepatitis B antibodiesNOVARTIS AG·Filed 2019·Granted Mar 19, 2024·2 cites·19 claims
- 0580US9683034B2Stable and soluble antibodies inhibiting TNFαESBATECH ALCON BIOMED RES UNIT·Filed 2016·Granted Jun 20, 2017·2 cites·19 claims
- 0679US8323647B2Humanized antibodies against the β-amyloid peptideEWERT STEFAN·Filed 2008·Granted Dec 4, 2012·5 cites·39 claims
- 0778US12331104B2Hepatitis B antibodiesNOVARTIS AG·Filed 2024·Granted Jun 17, 2025·0 cites·10 claims
- 0878US8853362B2Immunoglobulin frameworks which demonstrate enhanced stability in the intracellular environment and methods of identifying sameTISSOT KATHRIN·Filed 2003·Granted Oct 7, 2014·12 cites·9 claims
- 0971US2020165322A1Immunoglobulin frameworks which demonstrate enhanced stability in the intracellular environment and methods of identifying sameNOVARTIS AG·Filed 2019·Application pending·0 cites
- 1071US2024067750A1Factor xi antibodies and methods of useNOVARTIS AG·Filed 2023·Application pending·0 cites
- 1163US10570190B2Immunoglobulin frameworks which demonstrate enhanced stability in the intracellular environment and methods of identifying sameESBATECH ALCON BIOMED RES UNIT·Filed 2018·Granted Feb 25, 2020·0 cites·1 claims
- 1263US9315572B2Stable and soluble antibodies inhibiting TNF alphaESBATECH ALCON BIOMED RES UNIT·Filed 2014·Granted Apr 19, 2016·0 cites·18 claims
- 1362US9518108B2Immunoglobulin frameworks which demonstrate enhanced stability in the intracellular environment and methods of identifying sameESBATECH ALCON BIOMED RES UNIT·Filed 2014·Granted Dec 13, 2016·0 cites·10 claims
- 1461US8691228B2Stable and soluble antibodies inhibiting TNFαESBATECH ALCON BIOMED RES UNIT·Filed 2012·Granted Apr 8, 2014·0 cites·20 claims
- 1560US2020115468A1Factor xi antibodies and methods of useNOVARTIS AG·Filed 2019·Application pending·0 cites
- 1659US8389693B2Stable and soluble antibodies inhibiting TNFαEWERT STEFAN·Filed 2011·Granted Mar 5, 2013·0 cites·7 claims
- 1758US10125186B2Immunoglobulin frameworks which demonstrate enhanced stability in the intracellular environment and methods of identifying sameESBATECH ALCON BIOMED RES UNIT·Filed 2016·Granted Nov 13, 2018·0 cites·10 claims
- 1856US2020317816A1REVERSAL BINDING AGENTS FOR ANTI-FACTOR XI/XIa ANTIBODIES AND USES THEREOFNOVARTIS AG·Filed 2020·Application pending·0 cites
- 1953US9273126B2Humanized antibodies against the beta-amyloid peptideEWERT STEFAN·Filed 2012·Granted Mar 1, 2016·0 cites·9 claims
- 2051US2022025070A1Reversal binding agents for anti-factor xi/xia antibodies and uses thereofNOVARTIS AG·Filed 2019·Application pending·0 cites
- 2150US2010113355A1Novel antibody molecules and nucleic acids binding to fungal stress protein hsp90CHENNAMSETTY NARESH·Filed 2006·Application pending·0 cites
- 2249US2010322930A1Fibronectin-based binding molecules and their useKOLBINGER FRANK·Filed 2008·Application pending·0 cites
- 2347US2006127893A1Modification of human variable domainsEWERT STEFAN·Filed 2002·Application pending·0 cites
- 2445US2020308301A1Reversal binding agents for anti-factor xi/xia antibodies and uses thereofNOVARTIS AG·Filed 2018·Application pending·0 cites
- 2542US8400098B2Device and method of determining and defining a travel profile of a time-critical axleEWERT STEFAN·Filed 2007·Granted Mar 19, 2013·2 cites·13 claims
- 2636US2017198040A1ANTIBODIES TARGETING CD32b AND METHODS OF USE THEREOFNOVARTIS AG·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Stefan Ewert files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →